Back to today’s briefing

Story perspectives

Trump's Order Aims to Simplify Drug Manufacturing, Risks Costs

5/10/2025

43 3

Summary

Story summary

President Trump's May 5 executive order seeks to simplify regulations for U.S. pharmaceutical manufacturing, promising to cut costs and boost local production. Yet, hurdles like soaring labor expenses and slow approval times linger. While the initiative may ease some operational challenges, it risks driving up drug prices, especially for generics, threatening affordability for many.

1 of 1

Story summary

President Trump's May 5 executive order seeks to simplify regulations for U.S. pharmaceutical manufacturing, promising to cut costs and boost local production. Yet, hurdles like soaring labor expenses and slow approval times linger. While the initiative may ease some operational challenges, it risks driving up drug prices, especially for generics, threatening affordability for many.